FIELD: medicine, biotechnology. SUBSTANCE: derivatives of vasotocin of the formula where Y - homoglutamine or homocitrulline; X - -HN-CH(CO)(CH2)nNHQ; n = 1-3; Q - H, alanyl or L-2-aminobutyric acid. All derivatives of vasotocin were synthesized on applied biosystem 430A of peptide synthesizer using double connective program including the end-step after the second connection. Structure of the end peptide is confirmed by amino acid analysis and mass-spectrometry. EFFECT: improved method of synthesis. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE AGONISTS OF VASOPRESSIN RECEPTOR | 2005 |
|
RU2355701C2 |
V1A-RECEPTORS AGONISTS | 2013 |
|
RU2634617C2 |
HEPTAPEPTIDE OXYTOCIN ANALOGS | 1997 |
|
RU2180668C2 |
PEPTIDE COMPOUNDS | 2007 |
|
RU2415149C2 |
OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | 1995 |
|
RU2140790C1 |
COMPOSITIONS FOR NASAL ADMINISTRATION OF DESMOPRESSIN | 1994 |
|
RU2135204C1 |
POTASSIUM URETIC PEPTIDE | 2011 |
|
RU2454426C1 |
GNRH ANTAGONISTS MODIFIED AT POSITIONS 5 AND 6 | 1998 |
|
RU2199549C2 |
CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
Authors
Dates
1996-10-10—Published
1991-02-26—Filed